6505--Hydroxychloroquine SO4 Tablets

The Department of Veterans Affairs National Acquisition Center is seeking to procure Hydroxychloroquine SO4 200mg Tablets through a competitive solicitation (36E79725R0022) for VA, Department of Defense, Indian Health Service, Bureau of Prisons, and State Veterans Homes. The procurement will establish a pharmaceutical supply contract with a base year and four potential one-year option periods, using a lowest-price technically acceptable evaluation methodology. Offerors must be registered in the System for Award Management (SAM) and provide FDA-approved products that comply with current Good Manufacturing Practices. Proposals must include unique NDC numbers, pricing for the base year and all four option years, and incorporate a 0.5% Cost Recovery Fee. The solicitation response deadline was originally set for April 1, 2025, at 2:30 PM CT but was subsequently extended to April 8, 2025, at 2:30 PM CDT.

The solicitation is not set aside for any specific vendor category and will be distributed through Prime Vendor contractors. The estimated annual requirements include 163,395 bottles of 100-tablet packages and 25,853 bottles of 500-tablet packages, demonstrating significant pharmaceutical procurement volume. While specific award values are not explicitly stated, the contract's multi-year structure and comprehensive distribution plan suggest a substantial potential contract value. The place of performance will involve nationwide distribution through established Prime Vendor networks, serving multiple federal and state healthcare institutions. The contract's NAICS classification is Pharmaceutical Preparation Manufacturing (325412), and the Product Service Code is Drugs and Biologicals (6505), indicating a specialized pharmaceutical procurement process designed to meet comprehensive federal healthcare supply requirements.